Modulation Effects of Baduanjin Exercise on Subjective Cognitive Decline

  • STATUS
    Recruiting
  • End date
    Jun 30, 2024
  • participants needed
    120
  • sponsor
    Massachusetts General Hospital
Updated on 7 July 2021
dementia
mini-mental state examination
alzheimer's disease
cognitive decline
mental state examination
memory impairment
cognitive assessment
memory loss
mental deterioration

Summary

The aim of this study is to investigate the modulation effects of Baduanjin (BDJ), a simple and innovative mind-body exercise, on cognitive function, resting state functional connectivity, and brain morphometry in individuals with subjective cognitive decline (SCD). The results obtained will provide novel insights for improving the prevention of age-related cognitive decline and Alzheimer's disease.

Description

Subjective cognitive decline (SCD), the self-reported perception of memory or cognitive problems, is receiving increasing attention as a risk factor for the development of Alzheimer's disease (AD). Since SCD manifests before the onset of clinical impairment, it might be the optimal stage/window of time at which to intervene with preventative therapies for AD and age-related dementia before the progressive neurological loss and irreversible cognitive impairment.

Recently, mind-body interventions have demonstrated their potential in preventing cognitive decline. Nevertheless, these mind-body therapies encompass a family of complex practices, each with different characteristics and focus. Therefore, they may be associated with different mechanisms and treatment effects. Baduanjin (BDJ) is an innovative and simple mind-body exercise consisting of eight simple movements that can be easily practiced at home with video guidance, thereby making it a more suitable option for older adults with cognitive decline than other more complex exercises.

We believe that this study will 1) significantly improve the prevention of MCI and AD and directly benefit patients suffering from these highly prevalent disorders, 2) enhance the investigators' understandings of the neurobiology through which mind-body interventions affect cognition and health, and 3) advance the investigators' understandings of the pathophysiology and development of SCD, AD, and age-related dementia.

Details
Condition Cognitive Impairments, Cognitive Impairment, Cognitive Decline, neurocognitive disturbance, Mental Deterioration, Cognitive Dysfunction
Treatment Baduanjin exercise, Cognitive Fitness Program
Clinical Study IdentifierNCT04009382
SponsorMassachusetts General Hospital
Last Modified on7 July 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

- 80 years old
Self-reported experience of persistent decline in memory compared with a previous state (within the past 5 years), which was further confirmed by informants
Concerns regarding memory problems
Mini-Mental State Examination, Second Edition (MMSE-2) scores within the normal range
Montreal Cognitive Assessment scores within the normal range (adjusted for age, sex, and education)
Clinical Dementia Rating score of 0 (no memory loss or slight, inconsistent forgetfulness)

Exclusion Criteria

Unable to speak or read English
Diagnosis of depression
Other diseases that cause cognitive decline (e.g., traumatic brain injury, stroke, neurodegenerative diseases, brain tumor, Parkinson disease, encephalitis or epilepsy, thyroid dysfunction, severe anemia, syphilis)
History of psychosis or congenital mental growth retardation
Any delayed recall index greater than 1.5 SD below average on the California Verbal Learning Test, Second Edition
Failing the Memory items on the MMSE-2 and MDRS-2, as well as the CVLT-II criterion
Inability to participate in a 6-month intervention with a 3-month follow-up
Any item = 0 on the Lawton-Brody Instrumental Activities of Daily Living Scale for cognitive reasons
No available informant
Previous diagnosis of MCI, AD, or other age-related dementia
Previous Baduanjin experience
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note